Clinicians’ views of prescribing oral and intravenous bisphosphonates for osteoporosis: a qualitative study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Clinicians’ views of prescribing oral and intravenous bisphosphonates for osteoporosis: a qualitative study ; volume:24 ; number:1 ; day:29 ; month:9 ; year:2023 ; pages:1-10 ; date:12.2023
BMC musculoskeletal disorders ; 24, Heft 1 (29.9.2023), 1-10, 12.2023
- Creator
-
Bishop, Simon
Narayanasamy, Melanie Jay
Paskins, Zoe
Corp, Nadia
Bastounis, Anastasios
Griffin, Jill
Gittoes, Neil
Leonardi-Bee, Jo
Langley, Tessa
Sahota, Opinder
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12891-023-06865-1
- URN
-
urn:nbn:de:101:1-2024020613380545549811
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:24 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Bishop, Simon
- Narayanasamy, Melanie Jay
- Paskins, Zoe
- Corp, Nadia
- Bastounis, Anastasios
- Griffin, Jill
- Gittoes, Neil
- Leonardi-Bee, Jo
- Langley, Tessa
- Sahota, Opinder
- SpringerLink (Online service)
Other Objects (12)
A reappraisal of generic bisphosphonates in osteoporosis
Novel formulations of oral bisphosphonates in the treatment of osteoporosis
Correction: Novel formulations of oral bisphosphonates in the treatment of osteoporosis
Denosumab compared to bisphosphonates to treat postmenopausal osteoporosis: a meta-analysis
Sickle cell bone disease and response to intravenous bisphosphonates in children
Efficacy and safety of teriparatide vs. bisphosphonates and denosumab vs. bisphosphonates in osteoporosis not previously treated with bisphosphonates: a systematic review and meta-analysis of randomized controlled trials
Correction: Efficacy and safety of teriparatide vs. bisphosphonates and denosumab vs. bisphosphonates in osteoporosis not previously treated with bisphosphonates: a systematic review and meta-analysis of randomized controlled trials
Influence on persistence and adherence with oral bisphosphonates on fracture rates in osteoporosis
Once-weekly teriparatide improves glucocorticoid-induced osteoporosis in patients with inadequate response to bisphosphonates
Cost of non-persistence with oral bisphosphonates in post-menopausal osteoporosis treatment in France
The clinician’s guide to prevention and treatment of osteoporosis
Bisphosphonates and Implants
A reappraisal of generic bisphosphonates in osteoporosis
Novel formulations of oral bisphosphonates in the treatment of osteoporosis
Correction: Novel formulations of oral bisphosphonates in the treatment of osteoporosis
Denosumab compared to bisphosphonates to treat postmenopausal osteoporosis: a meta-analysis
Sickle cell bone disease and response to intravenous bisphosphonates in children
Efficacy and safety of teriparatide vs. bisphosphonates and denosumab vs. bisphosphonates in osteoporosis not previously treated with bisphosphonates: a systematic review and meta-analysis of randomized controlled trials
Correction: Efficacy and safety of teriparatide vs. bisphosphonates and denosumab vs. bisphosphonates in osteoporosis not previously treated with bisphosphonates: a systematic review and meta-analysis of randomized controlled trials
Influence on persistence and adherence with oral bisphosphonates on fracture rates in osteoporosis
Once-weekly teriparatide improves glucocorticoid-induced osteoporosis in patients with inadequate response to bisphosphonates
Cost of non-persistence with oral bisphosphonates in post-menopausal osteoporosis treatment in France
The clinician’s guide to prevention and treatment of osteoporosis
Bisphosphonates and Implants
A reappraisal of generic bisphosphonates in osteoporosis
Novel formulations of oral bisphosphonates in the treatment of osteoporosis
Correction: Novel formulations of oral bisphosphonates in the treatment of osteoporosis
Denosumab compared to bisphosphonates to treat postmenopausal osteoporosis: a meta-analysis
Sickle cell bone disease and response to intravenous bisphosphonates in children
Efficacy and safety of teriparatide vs. bisphosphonates and denosumab vs. bisphosphonates in osteoporosis not previously treated with bisphosphonates: a systematic review and meta-analysis of randomized controlled trials
Correction: Efficacy and safety of teriparatide vs. bisphosphonates and denosumab vs. bisphosphonates in osteoporosis not previously treated with bisphosphonates: a systematic review and meta-analysis of randomized controlled trials
Influence on persistence and adherence with oral bisphosphonates on fracture rates in osteoporosis
Once-weekly teriparatide improves glucocorticoid-induced osteoporosis in patients with inadequate response to bisphosphonates
Cost of non-persistence with oral bisphosphonates in post-menopausal osteoporosis treatment in France
The clinician’s guide to prevention and treatment of osteoporosis